181 related articles for article (PubMed ID: 37336248)
1. Serum glial fibrillary acidic protein and neurofilament light chain in treatment-naïve patients with unipolar depression.
Hviid CVB; Benros ME; Krogh J; Nordentoft M; Christensen SH
J Affect Disord; 2023 Oct; 338():341-348. PubMed ID: 37336248
[TBL] [Abstract][Full Text] [Related]
2. Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson's disease.
Mao S; Teng X; Li Z; Zu J; Zhang T; Xu C; Cui G
Brain Res; 2023 Apr; 1805():148271. PubMed ID: 36754139
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson's disease.
Teng X; Mao S; Wu H; Shao Q; Zu J; Zhang W; Zhou S; Zhang T; Zhu J; Cui G; Xu C
J Neurochem; 2023 Apr; 165(2):268-276. PubMed ID: 36776136
[TBL] [Abstract][Full Text] [Related]
4. Relationship between increased serum neurofilament light chain and glial fibrillary acidic protein levels with non-motor symptoms in patients with Parkinson's disease.
Yin P; Niu X; Guan C; Zhang Z; Liu Y; Li J; Cui G; Zan K; Xu C
Psychogeriatrics; 2024 Mar; 24(2):415-425. PubMed ID: 38339819
[TBL] [Abstract][Full Text] [Related]
5. Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy.
Rasing I; Voigt S; Koemans EA; de Kort AM; van Harten TW; van Etten ES; van Zwet EW; Stoops E; Francois C; Kuiperij BH; Klijn CJM; Schreuder FHBM; van der Weerd L; van Osch MJP; van Walderveen MAA; Verbeek MM; Terwindt GM; Wermer MJH
Alzheimers Res Ther; 2024 Apr; 16(1):86. PubMed ID: 38654326
[TBL] [Abstract][Full Text] [Related]
6. Serum neurofilament and glial fibrillary acidic protein in idiopathic and seropositive transverse myelitis.
Lee HL; Seok JM; Chung YH; Min JH; Baek SH; Kim SM; Sohn E; Kim J; Kang SY; Hong YH; Shin HY; Cho JY; Oh J; Lee SS; Kim S; Kim SH; Kim HJ; Kim BJ; Kim BJ
Mult Scler Relat Disord; 2023 Nov; 79():104957. PubMed ID: 37688927
[TBL] [Abstract][Full Text] [Related]
7. Plasma glial fibrillary acidic protein and neurofilament light chain in relation to disability worsening in multiple sclerosis.
Pauwels A; Van Schependom J; Devolder L; Van Remoortel A; Nagels G; Bjerke M; D'hooghe MB
Mult Scler; 2022 Oct; 28(11):1685-1696. PubMed ID: 36059263
[TBL] [Abstract][Full Text] [Related]
8. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
[TBL] [Abstract][Full Text] [Related]
9. Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers in Autism Spectrum Disorders: A Preliminary Study.
Simone M; De Giacomo A; Palumbi R; Palazzo C; Lucisano G; Pompamea F; Micella S; Pascali M; Gabellone A; Marzulli L; Giordano P; Gargano CD; Margari L; Frigeri A; Ruggieri M
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769380
[TBL] [Abstract][Full Text] [Related]
10. Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.
Klitholm M; Jeppesen AN; Christensen S; Parkner T; Tybirk L; Kirkegaard H; Sandfeld-Paulsen B; Grejs AM
Resuscitation; 2023 Dec; 193():109983. PubMed ID: 37778613
[TBL] [Abstract][Full Text] [Related]
11. Serum neurofilament-light and glial fibrillary acidic protein levels in hydroxychloroquine-treated primary progressive multiple sclerosis.
Camara-Lemarroy C; Silva C; Gohill J; Yong VW; Koch M
Eur J Neurol; 2023 Jan; 30(1):187-194. PubMed ID: 36214614
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal follow-up of serum biomarkers in patients with neuromyelitis optica spectrum disorder.
Kim H; Lee EJ; Kim S; Choi LK; Kim HJ; Kim HW; Chung K; Seo D; Moon S; Kim KK; Lim YM
Mult Scler; 2022 Apr; 28(4):512-521. PubMed ID: 34212756
[TBL] [Abstract][Full Text] [Related]
13. Utility of serum neurofilament light chain and glial fibrillary acidic protein as diagnostic biomarkers of freezing of gait in Parkinson's disease.
Liu X; Liu X; Liu Y; Yang B; Li Y; Li F; Qian K; Zu J; Zhang W; Zhou S; Zhang T; Liu J; Cui G; Xu C
Brain Res; 2024 Jan; 1822():148660. PubMed ID: 37924925
[TBL] [Abstract][Full Text] [Related]
14. Neurofilament light chain as a biomarker in neuromyelitis optica spectrum disorder: a comprehensive review and integrated analysis with glial fibrillary acidic protein.
Kim S; Lee JJ; Park JS; Kang M; Seok HY
Neurol Sci; 2024 Mar; 45(3):1255-1261. PubMed ID: 38141119
[TBL] [Abstract][Full Text] [Related]
15. Serum total tau, neurofilament light, and glial fibrillary acidic protein are associated with mortality in a population study.
Halloway S; Evans DA; Desai P; Dhana K; Beck T; Rajan KB
J Am Geriatr Soc; 2024 Jan; 72(1):149-159. PubMed ID: 37818793
[TBL] [Abstract][Full Text] [Related]
16. Association between serum neurofilament light chain levels and sleep disorders in patients with Parkinson's disease.
Li Y; Li F; Liu X; Zu J; Zhang W; Zhou S; Zhu J; Zhang T; Cui G; Xu C
Neurosci Lett; 2023 Aug; 812():137394. PubMed ID: 37437874
[TBL] [Abstract][Full Text] [Related]
17. A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
Bolsewig K; Hok-A-Hin YS; Sepe FN; Boonkamp L; Jacobs D; Bellomo G; Paoletti FP; Vanmechelen E; Teunissen CE; Parnetti L; Willemse EAJ
J Alzheimers Dis; 2022; 90(1):363-380. PubMed ID: 36120776
[TBL] [Abstract][Full Text] [Related]
18. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity-a multicentre study on Lithuanian and Swedish patients.
Veje M; Griška V; Pakalnienė J; Mickienė A; Bremell D; Zetterberg H; Blennow K; Lindquist L; Studahl M
Eur J Neurol; 2023 Oct; 30(10):3182-3189. PubMed ID: 37431060
[TBL] [Abstract][Full Text] [Related]
19. Serum glial fibrillary acidic protein and neurofilament light chain as biomarkers of retinal neurodysfunction in early diabetic retinopathy: results of the EUROCONDOR study.
Hernández C; Simó-Servat O; Porta M; Grauslund J; Harding SP; Frydkjaer-Olsen U; García-Arumí J; Ribeiro L; Scanlon P; Cunha-Vaz J; Simó R;
Acta Diabetol; 2023 Jun; 60(6):837-844. PubMed ID: 36959506
[TBL] [Abstract][Full Text] [Related]
20. Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
Akel S; Asztely F; Banote RK; Axelsson M; Zetterberg H; Zelano J
Epilepsia; 2023 Oct; 64(10):2690-2700. PubMed ID: 37469165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
